港股異動丨平安好醫生逆勢升超11%,創2023年8月以來新高
延續近期強勢,平安好醫生(1833.HK)今日繼續逆勢上升,盤中一度升超11%,報7.58港元,股價創2023年8月以來新高。平安好醫生在連續虧損9年後,今年上半年終於取得盈利,期內經調整盈利近9000萬元人民幣。平安好醫生11月宣佈建議宣派特別股息。根據公吿,公司計劃從公司儲備的股份溢價帳中向股東派發每股9.7港元的特別股息,目前,平安好醫生總股數近11.2億股,此次派發股息總額將達到108.5億港元。分析人士指出,公司目前市值不到百億,分紅規模卻高逾百億,如此大手筆的分紅,股價會否迎來反轉拭目以待。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.